Severance costs hit operating profits at Irish arm of pharmaceutical firm Roche

The main activity of the company is marketing and selling of Roche-branded prescription medicines in Ireland

Roche said they welcome the allocation of €30m for new and existing medicines in Budget 2026 here. File photo: Stefan Wermuth/Bloomberg

Severance costs totalling €890,000 contributed towards a drop in operating profits at the Irish arm of pharmaceutical giant, Roche, which reduced by 9% to €4.09m in 2024.

New accounts filed by Roche Products (Ireland) show that the firm recorded the fall in operating profits as revenues rose by 7% from €124.68m to €133.57m.